Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 14/20 | 0.61 |
| ▸ | NPC1 | O15118 | 12/20 | 0.61 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.59 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.59 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27941306 | 0.98 | RAB9A (0.59) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL27425755 | 0.96 | RAB9A (0.61) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL13844497 | 0.84 | RAB9A (0.53) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL12112412 | 0.83 | RAB9A (0.66) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL28938010 | 0.82 | PTPN1 (0.44) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL12586462 | 0.82 | RAB9A (0.49) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL4588205 | 0.81 | RAB9A (0.50) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL9409756 | 0.79 | HSD17B1 (0.53) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL2301990 | 0.79 | RAB9A (0.57) | RAB9ANPC1MEN1KMT2ANOTUM | |
| SCHEMBL14117652 | 0.79 | ACHE (0.52) | RAB9ANPC1CASP3SENP8SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115611921-B | Oxacillin acid amine salt and related crystal forms | 成都倍特药业股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117126118-A | Synthesis method of celecoxib | 上海应用技术大学 | 2023-11-28 | — | — | CN | claimed |
| US-20230339870-A1 | CINNAMIC AMIDE DERIVATIVE HAVING FXR ACTIVATING EFFECT, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT, AND METHOD FOR PREPARING THE SAME | KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION (KR) | 2023-10-26 | — | — | US | claimed |
| CN-115611921-A | Oxacillin acid amine salt and related crystal form | 成都倍特药业股份有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-107202777-A | A kind of small molecule chip, its construction method, its application and its detection method | 广州高通生物技术有限公司 | 2017-09-26 | — | — | CN | claimed |
| US-20100298392-A1 | Isoindoline Derivatives For The Treatment Of Arrhythmias | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | US | claimed |
| EP-2049484-A1 | ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS | AstraZeneca AB (SE) | 2009-04-22 | — | — | EP | claimed |
| WO-2008008022-A1 | ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS | ASTRAZENECA AB (SE) | 2008-01-17 | — | — | WO | claimed |
| US-20080015237-A1 | NEW COMPOUNDS I/418 | ASTRAZENECA AB (SE) | 2008-01-17 | — | — | US | claimed |
| WO-2007001335-A2 | RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-01-04 | — | — | WO | claimed |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-09-21 | — | — | US | claimed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | claimed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | claimed |
| US-20260027088-A1 | Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer | UNIV EMORY (US) | 2026-01-29 | — | — | US | disclosed |
| US-12478614-B2 | Inhibitors of glutathione s-transferases (GSTs) and NAD(P)H:quinone oxidoreductase 1 (NQO1), pharmaceutical compositions, and uses in managing cancer | EMORY UNIVERSITY (US) | 2025-11-25 | — | — | US | disclosed |
| CN-117126118-B | Ground-substituting test Synthesis method of shake | 上海应用技术大学 | 2025-07-25 | — | — | CN | disclosed |
| EP-0140949-A1 | NOVEL CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, THEIR USE IN THERAPY AS ANTIBIOTICS AND A PROCESS FOR THE PREPARATION OF THE NOVEL COMPOUNDS | BIOGAL GYOGYSZERGYAR (HU) | 1985-05-15 | — | — | EP | disclosed |
| WO-1984004096-A1 | NOVEL CEPHALOSPORIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, THEIR USE IN THERAPY AS ANTIBIOTICS AND A PROCESS FOR THE PREPARATION OF THE NOVEL COMPOUNDS | BIOGAL GYOGYSZERGYAR (HU) | 1984-10-25 | — | — | WO | disclosed |
| US-4282212-A | Immune-stimulating 1-(N-acylcarbamoyl)-2-cyanoaziridines | BOEHRINGER MANNHEIM GMBH (DE) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339870-A1 | CINNAMIC AMIDE DERIVATIVE HAVING FXR ACTIVATING EFFECT, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT, AND METHOD FOR PREPARING THE SAME | CEL, NR1H4, FXR1 | RAB9A 1432/4885NPC1 24/4885CASP3 3280/4885 |
| US-20080015237-A1 | NEW COMPOUNDS I/418 | KCNH1, KCNH2, KCNH3 | RAB9A 483/4885NPC1 790/4885CASP3 1034/4885 |
| US-12478614-B2 | Inhibitors of glutathione s-transferases (GSTs) and NAD(P)H:quinone oxidoreductase 1 (NQO1), pharmaceutical compositions, and uses in managing cancer | NQO1, GSTA1, GGT1 | RAB9A 1263/4885NPC1 619/4885CASP3 2513/4885 |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | CLSPN, LMAN2, RPN2 | RAB9A 20/4885NPC1 4197/4885CASP3 2634/4885 |
| US-20260027088-A1 | Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer | NQO1, GSTP1, GSTA1 | RAB9A 3015/4885NPC1 2838/4885CASP3 2930/4885 |
| US-20100298392-A1 | Isoindoline Derivatives For The Treatment Of Arrhythmias | KCNH1, KCNH2, KCNQ2 | RAB9A 899/4885NPC1 1060/4885CASP3 546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.